NYSE : SCD

LMP Capital and Income Fund Inc.

$15.48 USD

$0.02 (0.13%)

Volume
75.29K
Average Volume
72.59K
Market Capitalization
$5.19B
P/E Ratio
5.51
Dividend Yield
9.30%
Price Target
Year High
$16.18
Year Low
$13.79
Day High
Day Low
Payout Ratio
$0.53
Current Ratio
$0.11
Company Overview

NYSE

Kenneth Donald Fuller

Asset Management - Income

Financial Services

SCD

N/A

US

USD

212-805-2000

50208A102

0001270131

Liquidity Metrics

0.27

0.11

0.11

0.01

0.53

Sales & Valuation

$54.77M

446.39

0.90

708.97

0.32

Profitability

-$0.0358

-$820.21K

553.49%

553.49%

16.62%

12.80%

P/E Metrics

5.51

0.02

0.02

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

29.82

5/9

-$93.9M

$502.49M

$106.93M

$73.22M

Key Metrics (TTM)

$5.29B

455.35

77.35

0.11

16.62%

7.08%

18.14%

0.14%

$33.03

31 days

Company Executives
Name Title
Kenneth Donald Fuller Chairman, Chief Executive Officer and President
Peter J. Vanderlee Portfolio Manager
Harry David Cohen Portfolio Manager
Poll Results

No votes yet today — be the first to share your view!

About LMP Capital and Income Fund Inc. (NYSE:SCD) Stock

The LMP Capital and Income Fund Inc. operates as a closed-end balanced mutual fund, primarily overseen by Legg Mason Partners Fund Advisor, LLC. Additional management responsibilities are shared with Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. Its investment mandate extends globally, encompassing both public equity and fixed-income securities from businesses spanning various sectors. Key holdings include shares of large-capitalization firms, corporate bonds and notes of intermediate maturity with a minimum A- rating, both energy and non-energy master limited partnerships (MLPs), and real estate investment trusts (REITs). Portfolio construction is heavily influenced by a rigorous analysis of economic, market, and political la ... ndscapes, as well as fiscal and monetary policies, alongside thorough security valuation. Its performance is measured against two standard benchmarks: the U.S. Aggregate Index and the S&P 500 Index. Established in the United States on November 12, 2003, it was previously recognized as the Salomon Brothers Capital and Income Fund Inc.

Galmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market

2026-07-28 07:00:00

Aramchol meglumine is the only SCD1 inhibitor with an established clinical safety profile and confirmed blood-brain barrier (BBB) penetration. In order to improve patient convenience and long-term treatment adherence by Parkinson patients affected by dysphagia, an ODF formulation was developed demonstrating ~150% higher systemic bioavailability and ~300% significant increase in CNS exposure than conventional oral administration.

10 Best CEFs This Month: Average Yield Of Near 10% (July 2026)

2026-07-25 08:30:00

The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 10% plus yield and nearly 7.7% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.

LMP Capital and Income Fund (NYSE:SCD) Stock Price Passes Below 200 Day Moving Average – Time to Sell?

2026-07-22 03:42:23

LMP Capital and Income Fund Inc. (NYSE: SCD - Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $15.40 and traded as low as $15.35. LMP Capital and Income Fund shares last traded at $15.46, with a volume

Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol

2026-07-16 07:30:00

Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticles (LPNs) novel formulation of Aramchol that penetrates the heart tissue and redirects Aramchol's biodistribution away from liver-hepatocytes to the heart's muscle. Cardiac fibrosis is a major driver of chronic heart failure, the leading cause of death globally, responsible for an estimated 20.5 million deaths in 2025.

10 Best CEFs This Month: Average Yield Of Near 10% (June 2026)

2026-06-27 08:15:00

The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.8% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.

SCD: Gets The Job Done But Not The Most Efficient Income Fund

2026-06-18 02:42:46

LMP Capital and Income Fund maintains a 9.2% yield, with management expressing confidence in sustaining current distributions through August. Recent performance and distribution consistency have been concerns, leading to a hold rating on SCD. Franklin Templeton's management strategy and risk profile are key considerations for SCD's forward outlook.

Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5--11, at the European Hematology Association Congress and Announces Additional Global Regulatory Su

2026-06-11 03:00:00

[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVYÂ (exagamglogene autotemcel

10 Best CEFs This Month: Average Yield Of 9% Plus (May 2026)

2026-05-23 08:30:00

The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.

Frequently Asked Questions

What is the current LMP Capital and Income Fund Inc. (SCD) stock price?

LMP Capital and Income Fund Inc.(NYSE:SCD) stock price is $15.48 in the last trading session. During the trading session, SCD stock reached the peak price of $16.18 while $13.79 was the lowest point it dropped to. The percentage change in SCD stock occurred in the recent session was 0.13% while the dollar amount for the price change in SCD stock was $0.02.

SCD's industry and sector of operation?

The NYSE listed SCD is part of Asset Management - Income industry that operates in the broader Financial Services sector.

Who are the executives of SCD?

Kenneth Donald Fuller | Chairman, Chief Executive Officer and President
Peter J. Vanderlee | Portfolio Manager
Harry David Cohen | Portfolio Manager
|
|

How many employees does SCD have?

Number of SCD employees currently stands at None. SCD operates from 620 Eighth Avenue, New York City, NY 10018, US.

Link for SCD official website?

Official Website of SCD is: https://www.franklintempleton.com

How do I contact SCD?

SCD could be contacted at phone #212-805-2000 and can also be accessed through its website. SCD operates from 620 Eighth Avenue, New York City, NY 10018, US.

How many shares of SCD are traded daily?

The average number of SCD shares traded daily for last 3 months was 72.59K.

What is the market cap of SCD currently?

The market value of SCD currently stands at $5.19B with its latest stock price at $15.48